ALLO
Price
$2.10
Change
-$0.13 (-5.83%)
Updated
Aug 20 closing price
Capitalization
770.44M
70 days until earnings call
Intraday BUY SELL Signals
NBTX
Price
$43.68
Change
-$1.71 (-3.77%)
Updated
Aug 20 closing price
Capitalization
2.24B
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALLO vs NBTX

ALLO vs NBTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALLO vs. NBTX commentary
Aug 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and NBTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 21, 2026
Stock price -- (ALLO: $2.23 vs. NBTX: $45.39)
Brand notoriety: ALLO and NBTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 75% vs. NBTX: 101%
Market capitalization -- ALLO: $701.35M vs. NBTX: $2.07B
ALLO [@Biotechnology] is valued at $701.35M. NBTX’s [@Biotechnology] market capitalization is $2.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $139.93B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileNBTX’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • NBTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALLO and NBTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 6 TA indicator(s) are bullish while NBTX’s TA Score has 6 bullish TA indicator(s).

  • ALLO’s TA Score: 6 bullish, 4 bearish.
  • NBTX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, NBTX is a better buy in the short-term than ALLO.

Price Growth

ALLO (@Biotechnology) experienced а +7.73% price change this week, while NBTX (@Biotechnology) price change was +15.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.88%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was +2930.12%.

Reported Earning Dates

ALLO is expected to report earnings on Oct 29, 2026.

NBTX is expected to report earnings on Sep 30, 2026.

Industries' Descriptions

@Biotechnology (+1.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBTX($2.24B) has a higher market cap than ALLO($770M). NBTX YTD gains are higher at: 96.324 vs. ALLO (62.774).
ALLONBTXALLO / NBTX
Capitalization770M2.24B34%
EBITDA-160.41MN/A-
Gain YTD62.77496.32465%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash267MN/A-
Total Debt72.6MN/A-
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLONBTX
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ALLO
Daily Signal:
Gain/Loss:
NBTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UXRP9.941.13
+12.87%
ProShares Ultra XRP ETF
FDIS103.662.10
+2.07%
Fidelity MSCI Consumer Discret ETF
XSPI50.130.10
+0.21%
NEOS Boosted S&P 500 High Income ETF
XFIV48.260.08
+0.17%
BondBloxx Bloomberg FiveYrTrgDurUSTrsETF
LMNX18.59N/A
N/A
Defiance Daily Target 2X Long LMND ETF

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with EDIT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+9.85%
EDIT - ALLO
47%
Loosely correlated
+12.85%
AXON - ALLO
44%
Loosely correlated
+4.17%
VYGR - ALLO
43%
Loosely correlated
+3.33%
FDMT - ALLO
43%
Loosely correlated
+13.86%
ARRY - ALLO
43%
Loosely correlated
+2.50%
More

NBTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBTX has been loosely correlated with CGEN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NBTX jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBTX
1D Price
Change %
NBTX100%
+10.49%
CGEN - NBTX
35%
Loosely correlated
+2.52%
NTLA - NBTX
35%
Loosely correlated
+14.48%
FDMT - NBTX
32%
Poorly correlated
+13.86%
ALLO - NBTX
32%
Poorly correlated
+9.85%
ASMB - NBTX
32%
Poorly correlated
+5.32%
More